BIOMAT Database Logo BIOMAT Database Logo

[Prognostic value of tumor markers in cases of colorectal cancer: CEA and CA 19-9]. 1987

C Desaive, and R Servais, and J Collette, and D Denis, and J Y Reginster, and P Franchimont

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D012004 Rectal Neoplasms Tumors or cancer of the RECTUM. Cancer of Rectum,Rectal Cancer,Rectal Tumors,Cancer of the Rectum,Neoplasms, Rectal,Rectum Cancer,Rectum Neoplasms,Cancer, Rectal,Cancer, Rectum,Neoplasm, Rectal,Neoplasm, Rectum,Rectal Cancers,Rectal Neoplasm,Rectal Tumor,Rectum Cancers,Rectum Neoplasm,Tumor, Rectal
D002272 Carcinoembryonic Antigen A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment. Antigens, CD66e,CD66e Antigen,Antigen, CD66e,Antigen, Carcinoembryonic,CD66e Antigens
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D005260 Female Females

Related Publications

C Desaive, and R Servais, and J Collette, and D Denis, and J Y Reginster, and P Franchimont
Prognostic value of CEA and CA 19-9 tumor markers combined with cytology from peritoneal fluid in colorectal cancer.
April 2009, Annals of surgical oncology,
C Desaive, and R Servais, and J Collette, and D Denis, and J Y Reginster, and P Franchimont
CEA and CA 19-9 as prognostic indexes in colorectal cancer.
January 1999, Hepato-gastroenterology,
C Desaive, and R Servais, and J Collette, and D Denis, and J Y Reginster, and P Franchimont
Prognostic value of preoperative CEA and CA 19-9 levels in patients with colorectal cancer.
January 2011, Hepato-gastroenterology,
C Desaive, and R Servais, and J Collette, and D Denis, and J Y Reginster, and P Franchimont
[Comparison of the tumor markers CEA and CA 19-9 in colorectal diagnosis].
August 1984, Deutsche medizinische Wochenschrift (1946),
C Desaive, and R Servais, and J Collette, and D Denis, and J Y Reginster, and P Franchimont
[Value of the tumor markers CA 125, Ca 19-9, CA 15-3 and CEA in endometriosis].
August 1991, Geburtshilfe und Frauenheilkunde,
C Desaive, and R Servais, and J Collette, and D Denis, and J Y Reginster, and P Franchimont
Prognostic significance of CEA and CA 19-9 in colorectal cancer in Kuwait.
January 2000, The International journal of biological markers,
C Desaive, and R Servais, and J Collette, and D Denis, and J Y Reginster, and P Franchimont
Comparison of the tumor markers CEA, TPA, and CA 19-9 in colorectal carcinoma.
January 1987, Cancer,
C Desaive, and R Servais, and J Collette, and D Denis, and J Y Reginster, and P Franchimont
The tumor markers CEA, TPA and CA 19-9 in gastric cancer.
January 1988, Deutsche Zeitschrift fur Verdauungs- und Stoffwechselkrankheiten,
C Desaive, and R Servais, and J Collette, and D Denis, and J Y Reginster, and P Franchimont
Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
January 2000, Anticancer research,
C Desaive, and R Servais, and J Collette, and D Denis, and J Y Reginster, and P Franchimont
[Ca 12-5 in stomach and colorectal cancer. A comparison with the tumor markers CEA and Ca 19-9].
March 1986, Medizinische Klinik (Munich, Germany : 1983),
Copied contents to your clipboard!